Side effects: Generally aceclofenac is well tolerated .. The majority of side effects observed have been reversible and of a minor nature and include gastrointestinal disorders (dyspepsia, abdontinal pain, nausea and diarrhoea) and occasional occurance of dizziness. Dermatological side effects include pruritus and rash. Abnormal hepatic enzyme levels and raised serum creatinine have occasionally been reported.
Precautions and warnings: Aceclofenac should be adntinistered with caution ‘to patients with symptoms indicative of gastrointestinal disorders, with a history of peptic ulceration, ulcerative colitis, Crohn’s disease. hepatic porphyria. and coagulation disorders. Patients suffering from severe hepatic impairment must be monitored.
Pregnancy category:There is no information on the use of aceclofenac during pregnancy & in nursing mother. Therefore, aceclofenac should not be administered during pregnancy & breast feeding, unless the potential benefits to the mother outweigh the possible risks to the fetus & child respectively. In that cases the lowest effective doses should be adntinistered.
Child: There is no clinical data on the use of aceclofenac in children.
Therapeutic class: Aceclofenac
Dosage and administrations: Adults & elderly: The maximum recommended dose is 200mg daily, taken in two divided doses in the morning and in the evening. Children: There is no clinical data on the use of aceclofenac in children. Renal insufficiency: There is no evidence that the dosage of aceclofenac needs to be modified in patients with mild renal impairment. Hepatic insufficiency: The dose of aceclofenac should be reduced in patients with hepatic impairment. An initial daily dose of 100mg should be administered.
Indication: Aceclofenac is indicated for the relief of pain and inflammation in both acute and chronic pain like osteoanhritis, rheumatoid anhritis. ankylosing spondy litis. dental pain. Posttraumatic pain, low back pain, gynaecological pain etc.
Composition action: Known hypersensitivity to aceclofenac or aspirin or other NSAIDs. Patients with active or suspected peptic ulcer or gastrointestinal bleeding and moderate to severe renal impairment.d.
Reviews
There are no reviews yet.